My journey in the sciences has been shaped by resilience, determination, and a deep commitment to advocacy. As a first generation Greek American and the first woman in my family to pursue higher education, I experienced firsthand the barriers that come with navigating a complex medical system as the child of immigrants. Growing up, I watched my family face profound challenges when dealing with life changing diagnoses, particularly as non native English speakers. The emotional and logistical burdens of clinical trials, treatment decisions, and limited options were overwhelming, and I quickly learned how isolating these experiences could feel.
These hurdles ignited my passion for science and patient advocacy. I recognized that scientific advancement is not only about innovation, but also about equity, ensuring that discoveries translate into accessible, life changing care for all patients, regardless of background or circumstance. This perspective has guided both my academic and professional path.
I earned my Bachelor’s degree in Medical and Molecular Biology from MCPHS University, graduating with honors, and went on to complete a Master’s in Clinical Research, ranking in the top 10 percent of my class. These achievements were not without struggle; as a first generation student, I had to learn to navigate higher education largely on my own, without the roadmap or generational guidance many of my peers had. Yet those challenges only strengthened my determination to succeed and to open doors for others facing similar barriers.
Professionally, I have sought opportunities where I can directly impact patient care. My early training at Harvard Medical School gave me a rigorous grounding in science, while my work at Kymera Therapeutics and Alnylam Pharmaceuticals has allowed me to contribute to cutting edge research and global clinical trials. Leading a Phase 3 cardiomyopathy study across twenty countries has shown me the importance of addressing inequities in healthcare worldwide, particularly in regions where access to treatment remains limited.
Beyond my professional role, I co founded The Female Catalysts, an organization dedicated to helping women secure positions in STEM fields. Through mentorship, advocacy, and building networks of support, we strive to create opportunities for women who face systemic barriers in pursuing scientific careers. This work reflects my belief that representation and community are essential to transforming the culture of science and ensuring equity at every level.
The hurdles I faced as a first generation immigrant, including language barriers, limited resources, and the absence of a clear roadmap, ultimately became the foundation of my purpose. They shaped me into both a scientist and an advocate committed to making science more accessible, compassionate, and inclusive. Earning this scholarship would not only support my continued growth as a doctoral candidate, but also help me further my mission to ensure that no patient or family feels alone when facing the most difficult moments of their lives.